Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Musto D. The American Disease: Origins of Narrotic Control. New Haven, CT Yale University Press; 1973.
Mann JM, Tarantola DJM, eds. AIDS in the World II. New York and Oxford: Oxford University Press; 1996.
Des Jarlais DC, Stimson GV, Hagan H, et al. Emerging infectious diseases and the injection of illicit psychoactive drugs. Curr Issues Public Health 1996; 2:102–137.
Des Jarlais DC, Friedman SR. AIDS and IV drug use. Science 1989; 245578–579.
Third Quarterly Report, No 49. World Health Organization-European Commission. Collaborating Centre on AIDS; 1996.
Homberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996; 86(5):642–654.
Des Jarlais DC, Friedman SR, Novick D, et al. HIV-I infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261:1008–1012.
Wright N, Vanichseni S, Akarasewi P, et al. Was the 1988 HIV epidemic among Bangkok’s injecting drug users a common source outbreak? AIDS 1994; 8529–532.
Des Jarlais DC, Friedman SR, Choopanya K, et al. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992; 6:1053–1068.
Stimson GV. Recontruction of subregional diffusion of HIV infection among injecting drug users in southeast Asia: Implications for early intervention. AIDS 1994; 8(11):1630–1632.
Zheng X, Tian C, Zhang J, et al. Rapid spread of HIV among drug users and their wives in southwest China. 9th International Conference on AIDS, Berlin, 1993. Abstract No. 2766.
Sarkar S, Das N, Panda S, et al. Rapid spread of HIV among injecting drug user in north-eastern states of India. Bull Narcotics 1994; XLV91–105.
Jacquez J, Koopman J, Simon C, Longini I. Role of the primary infection in epidemic HIV infection of gay cohorts. J Acquir Immunodefic Syndr 1994; 7:1169–1184.
Ostrow DG. AIDS prevention through effective education. Daedalus 1989; 118:229–254.
Institute for Health Policy Studies. The public health impact of needle exchange programs in the United States and abroad: summary, conclusions and recommendations. School of Public Health, University of California, San Francisco, 1993.
Hartgers C, Buning EC, van Santen GW, et al. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behavior. AIDS 1989; 3:571–576.
Stimson GV. Syringe-exchange programmes for injecting drug users—Editorial review. AIDS 1989; 3:253–260.
Des Jarlais DC, Maynard H. Evaluation of needle exchange program on HIV risk behaviors: Supplemental final report. American Foundation for AIDS Research, New York, 1992.
Dolan KA, Stimson GV, Donoghoe M. Reductions in HIV risk behavior and stable HIV prevalence in syringe-exchange clients and other injectors in England. Drug Alcohol Rev 1993; 12:133–142.
Vlahov D, Astemborski J, Solomon L, Nelson KE. Field effectiveness of needle disinfection among injecting drug users. J Acquir Immunodefic Syndrs 1994; 7:760–766.
Titus S, Marmor M, Des Jarlais DC, et al. Bleach use and HIV seroconversion among New York City injection drug users. J Acquir Immunodefic Syndr 1994; 7:700–704.
Gleghorn AA, Doherty MC, Vlahov D, et al. Inadequate bleach contact times during syringe cleaning by injection drug users. J Acquir Immunodefic Syndr 1994; 7:762–772.
Caplehorn JR, Ross MW. Methadone maintenance and the likelihood of risky needle sharing. Int J Addict 1995; 30:685–698.
Neaigus A, Sufian M, Friedman SR, et al. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prevent 1990; 2:253–271.
Centers for Disease Control. Assessment of street outreach for HIV prevention-selected sites, 1991-1993. MMWR 42(45):873, 879–880.
Abdul-Quader AS, Des Jarlais DC, Tross S, et al. Outreach to injecting drug users and female sexual partners of drug users on the Lower East Side of New York City. Br J Addict 1992; 87: 519–526.
Weibel W, Jimenez A, Johnson W, et al. Positive effect on HIV seroconversion of street outreach intervention with IDU in Chicago: 1988-1992. 9th International Conference on AIDS, Berlin, 1993. Abstract No. WS-C15-2.
Canter ML, Petersen LR, Savage RB, Donagher J. Providing HIV counseling and testing services in methadone maintenance programs. AIDS 1990; 4(5):463–465.
Higgins DL, Galavotti C, O’Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991; 266:2419–2429.
Friedman SR, Des Jarlais DC, Neaigus A, et al. Organizing drug injectors against AIDS: Preliminary data on behavioral outcomes. Psychol Addict Behav 1992; 6:100–106.
Latkin CA, Mandell W, Vlahov D, et al. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: The SAFE study. Am J Commun Psychol 1996; 24:341–364
Vanichseni S, Sakuntanaga P. Results of three seroprevalence surveys for HIV and IVDU in Bangkok. Sixth International Conference on AIDS, San Francisco, CA, 1990.
Choopanya K, Vanichseni S, Des Jarlais DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991; 5:1509–1513.
Des Jarlais DC, Choopanya K, Wenston, et al. Risk reduction and stabilization of HIV sero-prevalence among drug injectors in New York City and Bangkok, Thailand. In: Rossi GB, Beth-Giraldo E, Chieco-Bianchi L, et al., (Eds.) Science Challenging AIDS. Basel: Karger, 1992; 207-213
Government of the Socialist Republic of Vietnam. Vietnam National Drug Abuse Control Plan. Hanoi; 1995
Vietnam National AIDS Committee. Annual Report. Hanoi; 1996.
Vietnam National AIDS Committee. Harm Reduction for Injecting Drug Users. Hanoi; 1995.
Quan VM, Chung A, Abdul-Quader AS. Feasibility of a syringe-needle exchange program in Vietnam. Substance Use Misuse 1998; 33(5):1–14.
SHARAN—Annual Report. New Delhi, 1995.
Kumar S, Daniels D. HIV risk reduction strategies among IDUs in Madras: Assessment research report. Madras, India; 1994.
Stimson GV. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bull Narcotics 1993; 45(1):3–17.
Indian Council of Medical Research. Annual Report. Calcutta, 1995.
Kumar S, Daniels D. Empirical evidence of behavior change. Paper presented at the Indo-US Workshop on Behavioral and Social Research on HIV Prevention. Bombay, 1996.
Panda S, Chattejee A, Sarkar S, et al. Injection drug use in Calcutta: A potential focus for an explosive HIV epidemic. Drug Alcohol Rev 1997; 16:17–23.
Hangzo C, Chatterjee A, Sarkar S, et al. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India. Addiction 1997; 92(7):813–820.
Chatterjee A, Hangzo CZ, Abdul-Quader AS, et al. Evidence of effectiveness of street-based peer outreach intervention to change behavior among injecting drug users in Manipur, India. XI International Conference on AIDS, Vancouver, 1996. Abstract No. 4975.
Peak A, Rana S, Mahajan SH, et al. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm reduction programme. AIDS 1995; 9:1067–1070.
Shreshtha DM, Shreshtha NM, Gautama K. Methadone treatment programme in Nepal: A one-year experience. J Nepal Med Assoc 1995; 33:33–46.
AIDSCAP/Family Health International. Harvard School of Public Health, and UNAIDS. The Status and Trends of the Global HIV/AIDS Pandemic Symposium Final Report. Vancouver, 1996.
Palaniappan N. Intervention among multiracial injecting drug users from different cultural and economical backgrounds. XI International Conference on AIDS, Vancouver, 1996. Abstract No. Mo.D. 1949.
Htoon MT, Lwin HH, San KO, et al. HIV/AIDS in Myanmar. AIDS 1994; 8(suppl 2):S105–S109.
Stimson GV. HIV infection and injecting drug use in the Union of Myanmar: Final report to the United Nations Drug Control Programme, Vienna, Austria, 1994.
Xia M, Kreiss JK, Holmes KK. Risk factors for HIV infection among drug users in Yunnan Province, China: Association with intravenous drug use and protective effect of boiling reusable needles and syringes. AIDS 1994; 8:1701–1706.
Zheng X, Zhang J, Qu X, et al. The sero-prevalence and incidence rates of HIV infection among IDUs by cohort study from 1992 to 1995 in Ruili and other counties of China. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Tu.C. 2515.
Libonatti O, Lima E, Peruga A, et al. Role of drug injection in the spread of HIV in Argentina and Brazil. Int J STD AIDS 1993; 4:135–141.
Fay O, Taborda M, Fernandez A, et al. HIV seroprevalence among different communities in Argentina after four years of surveillance. VII International Conference on AIDS, Florence, Italy; 1991. Abstract No. M.C.3263.
Chequer P, Castilho E, Gomes MRO, et al. Fifteen years of AIDS epidemic in Brazil: Trends over time and perspectives. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Mo.C.1439.
Rangel A, Telles P, Bastos F, et al. HIV risk in 1DUs in Rio de Janeiro: Psychological predictors and implications for intervention. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Tu.C.2495.
de Carvalho HB, Mesquita F, Massad E, et al. HIV and infection of similar transmission patterns in a drug injectors community of Santos, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12(1):84–92.
Loures LA, Bittencourt L, Marques F, et al. Dealing with a paradox: The national syringe exchange program in Brazil. XI International Conference on AIDS, Vancouver; 1996. Abstract No. We. C.3562.
Bueno RC, Mesquita F, Haiek R, et al. Bleaching among IDUs in the city of Santos: Results of an intervention by an outreach team. XI International Conference on AIDS, Vancouver; 1996. Abstract No. Pub.C.1259.
Conte M, ďAvila S, Mayer R, et al. The syringe pass. AIDS stay: AIDS prevention program for injection drug users. XI International Conference on AIDS, Vancouver; 1996. Abstract No. We.C.3567.
Stimson GV. The global diffusion of injecting drug use: Implications for HIV infection. VIII International Conference on AIDS, Amsterdam; 1992. Abstract No. 1748.
Brettle RP. HIV and harm reduction for injection drug users. AIDS 1991; 5:125–136.
Des Jarlais DC, Friedman SR, Ward TP. Harm reduction: A public health response to the AIDS epidemic among injecting drug users. Ann Rev Public Health 1993; 14:413–450.
Heather N, Wodak A, Nadelmann E, O’Hare P, eds. Psychoactive Drugs and Harm Reduction: From Faith to Science. Whurr Publishers, London; 1993.
Jacquez J, Koopman J, Simon C, Longini I. Role of the primary infection in epidemic HIV infection of gay cohorts. J Acquir lmmunodefic Syndr 1994; 7:1169–1184.
Friedman SR, Des Jarlais DC, Ward TP, et al. Drug injectors and heterosexual AIDS. In: L Sherr, ed. AIDS and the Heterosexual Population. Chur, Switzerland: Harwood Academic Publishers; 1994; 41–55.
Ball A, Des Jarlais DC, Donoghoe M, et al. Multi-centre Study on Drug Injecting and Risk of HIV Infection. Geneva: World Health Organization; 1994.
Laumann EO, Gagnon JH, Michael RT, Michaels S. The Social Organization of Sexality: Sexual Practices in the United States. Chicago: University of Chicago Press; 1994.
Vanichseni S, Des Jarlais DC, Choopanya K, et al. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS 1993; 7: 887–891.
Desenclos JC, Papaevangelou G, Ancell-Park R. Knowledge of HIV serostatus and preventive behavior among European injecting drug users. AIDS 1993; 7:1371–1377.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Abdul-Quader, A.S., Des Jarlais, D.C., Chatterjee, A., Hirky, A.E., Friedman, S.R. (2002). Interventions for Injecting Drug Users. In: Gibney, L., Di Clemente, R.J., Vermund, S.H. (eds) Preventing HIV in Developing Countries. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/0-306-47157-4_13
Download citation
DOI: https://doi.org/10.1007/0-306-47157-4_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45961-0
Online ISBN: 978-0-306-47157-5
eBook Packages: Springer Book Archive